Additionally, a higher proportion of patients using GLP-1 RAs developed acute respiratory failure compared with patients not using GLP-1 RAs (799 [13.5%] vs 40 060 [11.1%]; P < .001). The gene discussed is GLP1R; the disease is acute respiratory failure.